Article info
PDFOvarian Cancer
Activity of Bevacizumab in Patients With Low-Grade Serous Ovarian Carcinoma
- Address correspondence and reprint requests to Peter G. Rose, MD, Cleveland Clinic Health System, 9500 Euclid Ave, Cleveland, OH 44195. E-mail: rosep{at}ccf.org.
Citation
Activity of Bevacizumab in Patients With Low-Grade Serous Ovarian Carcinoma
Publication history
- Received December 29, 2015
- Accepted March 31, 2016
- First published July 1, 2016.
Online issue publication
February 27, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2016 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.